FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
WuXi Biologics (Cayman) Inc. Stock AnalysisComprehensive stock analysis for WuXi Biologics (Cayman) Inc. (WXIBF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWXIBF
WXIBF
WuXi Biologics (Cayman) Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WXIBF
Home🔹Stocks🔹WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

WXIBF•OTC

WuXi Biologics (Cayman) Inc.

WXIBF•OTC
Market cap
$21.30B
Sentiment

Your view on WXIBF

Mkt Cap
$21.30B
Sentiment
Your view
WXIBF
WuXi Biologics (Cayman) Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WXIBF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About WuXi Biologics (Cayman) Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Zhisheng Chen
Headquarters
No. 108, Meiliang Road, Wuxi, CN
Industry
Biotechnology
Sector
Healthcare
CEO
Zhisheng Chen
Headquarters
No. 108, Meiliang Road, Wuxi, CN
Description

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News